Torno Capital, LLC Ironwood Pharmaceuticals Inc Transaction History
Torno Capital, LLC
- $2.13 Trillion
- Q2 2024
A detailed history of Torno Capital, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Torno Capital, LLC holds 103,000 shares of IRWD stock, worth $464,530. This represents 0.06% of its overall portfolio holdings.
Number of Shares
103,000Holding current value
$464,530% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$97.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$73.9 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$41.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$40.2 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $691M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...